(READ) Review shows Merck’s newly-approved pill for Covid-19, only 30% effective


Below is an excerpt from Medpage Today. With the release of updated data, oral antiviral molnupiravir to treat high-risk COVID-19 showed only a 30% reduction in the risk of hospitalization and death, according to briefing documents from FDA staff. The agent’s sponsor, Merck, submitted data from the interim analysis of its phase III trial with […]

Continue reading (READ) Review shows Merck’s newly-approved pill for Covid-19, only 30% effective on sharylattkisson.com.

0 0 votes
Article Rating

Support Sharyl Attkisson

Order the New York Times bestseller “The Smear” today online or borrow from your library

FULL MEASURE NEWS

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

More from Sharyl Attkisson: